Energy Cost During the 6-Minute Walk Test and Its Relationship to Real-World Walking After Stroke: A Correlational, Cross-Sectional Pilot Study

2019 ◽  
Vol 99 (12) ◽  
pp. 1656-1666
Author(s):  
Jean A M Ribeiro ◽  
Simone G Oliveira ◽  
Luciana Di Thommazo-Luporini ◽  
Clara I Monteiro ◽  
Shane A Phillips ◽  
...  

Abstract Background After experiencing stroke, individuals expend more energy walking than people who are healthy. However, among individuals who have experienced stroke, the correlation between the energy cost of walking, as measured by validated tests (such as the 6-minute walk test), and participation in walking, as measured by more sensitive tools (such as an ambulatory activity monitor), remains unknown. Objective The main objective of this study was to determine whether the energy cost of walking is correlated with participation in walking. Design This study was a correlational, cross-sectional pilot study. Methods Data from 23 participants who had experienced chronic stroke were analyzed. On the first day, data on oxygen uptake were collected using a portable metabolic system while participants walked during the 6-minute walk test. Then, the ambulatory activity monitor was placed on the participants’ nonparetic ankle and removed 9 days later. The energy cost of walking was calculated by dividing the mean oxygen uptake recorded during the steady state by the walking speed. Results The energy cost of walking was correlated with the following: the number of steps (Spearman rank correlation coefficient [rs] = −0.59); the percentage of time spent in inactivity (rs = 0.48), low cadence (rs = 0.67), medium cadence (rs = −0.56), high cadence (rs = −0.65), and the percentages of steps taken at low cadence (rs = 0.65) and high cadence (rs = −0.64). Limitations Individuals who were physically inactive, convenience sampling, and a small sample size were used in this study. Conclusions Higher energy costs of walking were associated with fewer steps per day and lower cadence in real-world walking in individuals who had experienced stroke.

2018 ◽  
Vol 66 ◽  
pp. S8-S9
Author(s):  
I. Carpinella ◽  
E. Gervasoni ◽  
D. Anastasi ◽  
M. Ferrarin ◽  
D. Cattaneo

Heart & Lung ◽  
2005 ◽  
Vol 34 (2) ◽  
pp. 126-135 ◽  
Author(s):  
Karen J. Radke ◽  
Kathleen B. King ◽  
Martha L. Blair ◽  
Patricia G. Fitzpatrick ◽  
Deborah H. Eldredge

2018 ◽  
Vol 20 (4) ◽  
pp. 158-163 ◽  
Author(s):  
David A. Scalzitti ◽  
Kenneth J. Harwood ◽  
Joyce R. Maring ◽  
Susan J. Leach ◽  
Elizabeth A. Ruckert ◽  
...  

Abstract Background: Persons with multiple sclerosis (MS) commonly have difficulty walking. The 6-Minute Walk Test (6MWT) assesses functional capacity but may be considered burdensome for persons with MS, especially those with higher disability levels. The 2-Minute Walk Test (2MWT) may be an alternative measure to the 6MWT. The purpose of this study was to investigate the validity of the 2MWT in persons with MS. Methods: Twenty-eight ambulatory persons with MS aged 18 to 64 years participated in this cross-sectional study. Participants completed five measures of walking performance (2MWT, 6MWT, usual and fast gait speed, and Timed Up and Go test) and two functional measures (Berg Balance Scale and five-times sit-to-stand test) during a testing session. Participants were classified into two subgroups based on Disease Steps scale classification. Results: The 2MWT was significantly correlated with the 6MWT (r = 0.947), usual gait speed (r = 0.920), fast gait speed (r = 0.942), the Timed Up and Go test (r = −0.911), and other functional measures. The 2MWT explained 89% of the variance seen during the 6MWT. The distances completed on the 2MWT and 6MWT accurately distinguished the subgroups. Conclusions: This study demonstrated good construct and discriminant validity of the 2MWT in persons with MS, providing an efficient and practical alternative to the 6MWT. Validation of the 2MWT with other functional measures further supports these findings.


2017 ◽  
Vol 21 (5) ◽  
pp. 350-356 ◽  
Author(s):  
Alexandher Negreiros ◽  
Rosimeire Simprini Padula ◽  
Rosane Andrea Bretas Bernardes ◽  
Mônica Vasconcelos de Moraes ◽  
Raquel Simoni Pires ◽  
...  

2018 ◽  
Vol 252 ◽  
pp. 136-139 ◽  
Author(s):  
Paola Beltrán ◽  
Patricia Palau ◽  
Eloy Domínguez ◽  
Mercedes Faraudo ◽  
Eduardo Núñez ◽  
...  

2019 ◽  
Vol 74 (Supplement_1) ◽  
pp. S32-S37 ◽  
Author(s):  
Karol M Pencina ◽  
Zhuoying Li ◽  
Monty Montano

Abstract Background The use of circulating clinically routine biomarkers and volitional physical activity using wristband accelerometry in preclinical middle-aged adults may provide sensitive measures of physical function and predict sooner the onset of age- and HIV-related physical decline. Methods Nested cross-sectional cohort study of adult men 50–65 years old with HIV infection on potent antiretroviral therapy and uninfected control participants within the Boston metropolitan area. Gait speed derived from wristband accelerometry, gait speed derived from a standardized 6-minute walk test, cellular immune biomarker levels (CD4 T cell, CD8 T cell), and serum anabolic biomarker levels (total and free testosterone, and sex-hormone-binding globulin) were measured. Results Of the five measured biomarkers, four were significantly associated with volitional gait speed based on accelerometry, whereas only one was associated with gait speed based on the 6-minute walk test collected in a laboratory environment. Conclusion Levels of selected immune and anabolic biomarkers were associated with volitional physical activity in middle-aged individuals. Digital and circulating biomarkers may be useful in future studies designed to identify presymptomatic individuals at increased risk for age- and HIV-associated functional decline.


2021 ◽  
Vol 5 (1) ◽  
Author(s):  
Monira Aldhahi ◽  
Shipra Puri ◽  
Vivek Jain ◽  
Jeffrey E. Herrick

Abstract Background Autonomic dysregulation associated with obstructive sleep apnea (OSA) may limit cardiopulmonary responses to exercise, which, in turn, may impair functional aerobic capacity (FAC) and walking economy. We aimed to characterize walking economy and FAC in OSA patients compared with healthy adults (non-OSA) and examine their relationship with OSA severity (apnea-hypopnea index [AHI]). Methods A total of 26 adults (OSA, n = 13; non-OSA, n = 13) participated in this cross-sectional study. In this study, the participants with OSA were between the ages of 25 and 60 years, with a body mass index of 25 kg/m2 to 39 kg/m2, and who had undergone a recent third-party sleep study with an AHI of 5 or greater. Participants completed a maximal integrated cardiopulmonary exercise test, three separate exercise bouts of constant work rate (CWR) treadmill test at 85% of anaerobic threshold (AT), and a 10-min walk test (10MWT). Multiple linear regression analysis corrected for weight, age, and BMI were performed to examine the associations. Results There were significant differences between OSA and non-OSA participants in VO2peak (29.7 ± 5.6 mL/kg/min vs. 37.5 ± 6.5 mL/kg/min, p = 0.03) and Net VO2 during CWR (12.7 ± 5 vs.19 ± 6 mL/kg/min, p = 0.02). The 10MWT speed and distance were significantly lower in the OSA group (all p < 0.001). The energy cost of walking during submaximal exercise and 10-min walk test was higher among patients with OSA (all p < 0.001). The AHI scores were associated with 10MWT distance (R2 = 0.85, p < 0.001), energy cost of walking (R2 = 87, p < 0.001), and VO2 at anaerobic threshold (R2 = 0.92, p < 0.001). Conclusions The findings of this study show that patients with OSA have reduced FAC and a higher energy cost of walking. AHI explained 87% of variance in the energy cost of walking during the 10MWT. The results suggest that individuals with more severe obstructive sleep apnea experience greater impairment in functional performance.


2020 ◽  
pp. 1-2
Author(s):  
Manish Meena ◽  
Aashish Kumar Singh* ◽  
Shashi Prakash Agnihotri

Background: Six minute walk test (6MWT), represent a useful marker for exercise capacity and dynamic hyperination of COPD patients.Highresolution computed tomography (HRCT) has allowed in detection of airway wall abnormalities and emphysema, whose extent may correlate with the clinical severity of the disease in COPD patients. Material & methods: A cross sectional study was carried in 100 COPD patients attending Department of Respiratory Medicine, Institute of respiratory diseases, SMS Medical College, Jaipur, during June 2018 to May 2019.All patients underwent clinically (Modied Medical Research Council), radiologically (HRCT) &6MWT. Results:The 6MWTshowed that a negative correlation to dyspnea (mMRC grading), emphysema score & post FEV1% predicted (p<0.0001). Conclusion:The HRCTemphysema score can be used as an initial parameter for identify patients with high risk for COPD.


Sign in / Sign up

Export Citation Format

Share Document